🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsCost comparison: oral vs injectable semaglutide — my results so far Page 4

Cost comparison: oral vs injectable semaglutide — my results so far

pam_stl Tue, Feb 11, 2025 at 7:28 PM 17 replies 1,704 viewsPage 4 of 4
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Feb 12, 2025 at 3:20 PM#16

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

44 17Dr.LipidDallas, alex_tucson, kevin_tulsa and 41 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Feb 12, 2025 at 5:43 PM#17
wendy_avl said:
If you are going to change something, change one thing and give it long enough to express itself.

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

45 18LeilaHI, marcus_mpls, DeniseRN_TPA and 42 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Feb 12, 2025 at 8:06 PM#18

Adding the numbers, since they settle part of this. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

46 19WendyG_ATL, SaraMom3, Dr.MetabolicMD and 43 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Feb 12, 2025 at 10:29 PM#19

A narrower follow-up, since the general answer is now clear:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

47 20BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 44 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 13, 2025 at 12:52 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.

19 17PurityPaulOR, MaxMetOK, MounjBrad and 16 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register